All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

3,685

Reset

3,685 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • MRG004APhase 31 trial

    Lepu Biopharma Co., Ltd. · Advanced Pancreatic Cancer

  • mRNA-1018-H5Phase 31 trial

    Moderna · Influenza

  • MSP01-ROrafang TabPhase 31 trial

    Mather's Pharm. Co., Ltd. · Colonoscopy, Bowel Preparation

  • MSP01-TPhase 31 trial

    Mather's Pharm. Co., Ltd. · Colonoscopy, Bowel Preparation

  • N0728Phase 31 trial

    Eurofarma Laboratorios S.A. · Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms

  • N1087Phase 31 trial

    Eurofarma Laboratorios S.A. · Female Pattern Hair Loss, Female Pattern Hair Loss, Androgenic Alopecia

  • NB003Phase 31 trial

    Ningbo Newbay Technology Development Co., Ltd · GIST - Gastrointestinal Stromal Tumor, Advanced

  • NBP608Mid Potency, PotencyPhase 31 trial

    SK Bioscience Co., Ltd. · Varicella (Chickenpox)

  • NEMO-103Phase 31 trial

    Inventera Inc. · Rotator Cuff Tear, Labral Tear, Rotator Cuff Tendinosis

  • New of NiraparibPhase 31 trial

    Johnson & Johnson (Janssen) · Castration-Resistant Prostatic Cancer

  • Linnaeus Therapeutics, Inc. · Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma

  • NofazinlimabPhase 31 trial

    CStone Pharmaceuticals · Hepatocellular Carcinoma

  • NoiiglutidePhase 31 trial

    Jiangsu HengRui Medicine Co., Ltd. · Type 2 Diabetes

  • Supergene, LLC · Pulmonary Embolism

  • Supergene, LLC · Ischemic Stroke, Acute

  • NP-101Phase 31 trial

    Novatek Pharmaceuticals · Gastroenteropancreatic Neuroendocrine Tumors

  • NRT6003Yttrium-90 carbon microspheresPhase 31 trial

    Chengdu New Radiomedicine Technology Co. LTD. · Unresectable Hepatocellular Carcinoma

  • NRX-101Phase 31 trial

    NeuroRx, Inc. · Treatment Resistant Depression, Treatment Resistant Depression (TRD)

  • NTCB01-1Phase 31 trial

    Yuhan Corporation · Parenteral Nutrition

  • NTCB02-1Phase 31 trial

    Yuhan Corporation · Parenteral Nutrition

  • NTLA-2002Phase 31 trial

    Intellia Therapeutics · Hereditary Angioedema

  • NTQ1062Phase 31 trial

    Nanjing Chia-tai Tianqing Pharmaceutical · HR Positive/HER2 Negative Advanced or Metastatic Breast Cancer

  • NVD003Phase 31 trial

    Novadip Biosciences · Congenital Pseudarthrosis of Tibia

  • NVXC19EU licensed, standalonePhase 31 trial

    Sanofi · Immunization, Healthy Volunteers, COVID-19 Immunization

  • NXC-201Phase 31 trial

    Nexcella Inc. · Light Chain (AL) Amyloidosis

  • OCU410Phase 31 trial

    Ocugen · Dry Age-related Macular Degeneration

  • OCU410STPhase 31 trial

    Ocugen · Stargardt Disease

  • Olaparib phasePhase 31 trial

    AstraZeneca · Advanced or Recurrent Endometrial Cancer

  • OMA102Phase 31 trial

    EMS · Female Pattern Baldness

  • OPC-1085ELPhase 31 trial

    Otsuka · Open Angle Glaucoma or Ocular Hypertension

  • Alumis Inc · Plaque Psoriasis, Psoriasis (PsO), Psoriasis

  • OtaplimastatSP-8203Phase 31 trial

    Shin Poong Pharmaceutical Co. Ltd. · Ischemic Stroke

  • PaxlitaxelPhase 31 trial

    Akeso · Advanced Squamous Non Small Cell Lung Cancer

  • PCV13iPhase 31 trial

    CanSino Biologics Inc. · Pneumococcal Infections, Streptococcal Infections, Bacterial Infections

  • Jiangsu Hansoh Pharmaceutical Co., Ltd. · Advanced or Metastatic NSCLC

  • PF-06823859Phase 31 trial

    Pfizer · Myositis

  • PF-06838435fidanacogene elaparvovecPhase 31 trial

    Pfizer · Hemophilia B

  • PF04518600Phase 31 trial

    Pfizer · Advanced Malignancies, NSCLC, Ovarian Cancer

  • PF614Phase 31 trial

    Ensysce Biosciences · Postoperative Pain, Acute

  • PG-011GelPG-011Gel 3%Phase 31 trial

    Prime Gene Therapeutics Co., Ltd. · Atopic Dermatitis

  • Suzhou Suncadia Biopharmaceuticals Co., Ltd. · NMIBC

  • PJ009Phase 31 trial

    Chongqing Peg-Bio Biopharm Co., Ltd. · Short Bowel Syndrome

  • PLG0206Phase 31 trial

    Peptilogics · Prosthetic-joint Infection

  • PlinabulinPhase 31 trial

    BeyondSpring Pharmaceuticals Inc. · Non-Small Cell Lung Cancer, Non-squamous Non-Small Cell Lung Cance

  • ponsegromabPhase 31 trial

    Pfizer · Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma

  • Pre-screening PhasePhase 31 trial

    Insud Pharma · Soil-Transmitted Helminths

  • Prevenar 13Phase 31 trial

    Sinovac Life Sciences Co., Ltd. · Pneumococcal Infectious Diseases

  • Prevenar 20Phase 31 trial

    Pfizer · Healthy

  • prolgolimabBCD-100, FortecaPhase 31 trial

    Biocad · Melanoma, Melanoma (Skin), Melanoma Stage III

  • mAbxience Research S.L. · Rheumatoid Arthritis (RA)

NewerPage 26 of 74Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.